Related Experiment Video
Updated: Jul 22, 2026
07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Primary sclerosing cholangitis in childhood.
Gastroenterology
|May 1, 1987
Summary
Primary sclerosing cholangitis (PSC) in children is often associated with inflammatory bowel disease. Early diagnosis via ERCP suggests PSC may be more common in pediatric populations than previously thought.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Immunology
Background:
- Primary sclerosing cholangitis (PSC) is a rare, chronic liver disease characterized by bile duct inflammation and fibrosis.
- Association between PSC and inflammatory bowel disease (IBD) is well-established in adults, but less understood in pediatric cases.
Purpose of the Study:
- To describe a cohort of pediatric patients diagnosed with PSC.
- To investigate the association between PSC and chronic inflammatory bowel disease in children.
- To assess the utility of ERCP in diagnosing pediatric PSC and its potential incidence.
Main Methods:
- Retrospective review of 13 pediatric patients diagnosed with PSC confirmed by ERCP.
- Assessment of clinical features and diagnostic timelines for co-existing chronic inflammatory bowel disease.
- Evaluation of laboratory findings, including immunoglobulin G levels and autoantibodies.
- Analysis of treatment outcomes with immunosuppressants and follow-up assessments.
Main Results:
- Nine out of thirteen children had concurrent or preceding chronic inflammatory bowel disease.
- One additional patient had microscopic colitis identified on biopsy.
- Elevated IgG and positive autoantibodies were common, except in patients on immunosuppressants.
- Immunosuppressant therapy showed modest symptomatic and biochemical improvement in 7 patients.
Conclusions:
- Pediatric PSC frequently co-exists with chronic inflammatory bowel disease, including microscopic colitis.
- Increased utilization of ERCP has likely led to earlier and more frequent diagnosis of PSC in children.
- The findings suggest a potentially higher incidence of pediatric PSC than previously reported.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...